Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on August 5, 2025
Osteogenesis – Angiogenesis Coupling via Interlineage Paracrine Signaling
EIN Presswire
·
August 5, 2025
Single-cell transcriptomics reveal a distinct type of progenitor cell that supports angiogenesis and odontogenesis, leading to periodontal bone regeneration. CHINA, August 5, 2025 /EINPresswire.com/ -- The precise mechanism of cellular condensation and …
Business Reporter: Optimising hybrid multicloud environments
EIN Presswire
·
August 5, 2025
How advanced converge cloud technology can drive efficiency and sustainability LONDON, UNITED KINGDOM, August 5, 2025 /EINPresswire.com/ -- In an article published on Business Reporter, Sammy Zoghlami, SVP EMEA at Nutanix explains how hyperconverged …
Carbon Dioxide Incubators Market to Hit USD 983.3 Million by 2035 Amid Rising Biotech and Cell Culture Demands
EIN Presswire
·
August 5, 2025
Growing demand for advanced cell culture solutions and biotech research is fueling strong expansion in the carbon dioxide incubators market. ROCKVILLE, MD, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The global carbon dioxide (CO₂) incubators …
Radical Feng Shui: Energy & Performance Expert Redesigns Living and Working Environments for Clarity and Momentum
EIN Presswire
·
August 5, 2025
Blending ancient Eastern wisdom with modern Western performance science, Ulrike Oswald is reshaping how professionals think about their work space environment. BARCELONA, SPAIN, August 5, 2025 /EINPresswire.com/ -- In a bold move blending ancient …
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
GlobeNewswire
·
August 5, 2025
DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced …
Envision Pharma Group appoints Tom Langan as Chief Executive Officer
GlobeNewswire
·
August 5, 2025
Envision Pharma Group appoints Tom Langan as Chief Executive Officer Leading industry executive with 30 years’ of experience providing technology-enabled solutions to life sciences companies Fairfield, Connecticut, USA, and Horsham, United Kingdom - August …